Besides the well-documented role of TLR4 and its specific ligand, lipopolysaccharide, in disease pathogenesis in NAFLD [8], other TLRs are emerging as potentially implicated in the development and progression of liver damage in NAFLD. Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.